Patent Assignment
Reel/Frame 061808/0455
Change of Name
Recorded: 2022-10-31
Pages: 4
Assignor
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Axl Kinase Inhibitors and Use of the Same
Application:
17/836,698 →
Publication:
US 2023/0165857
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 31, 2022
From: SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; FLYNN, PAUL; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061594/0229 →
Assignment of Assignor's Interest
Oct 31, 2022
From: TOMIMATSU, NOZOMI; FUJIMURA, KEN; UMEHARA, HIROKI; NONOYAMA, AKIHITO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 061594/0359 →
Assignment of Assignor's Interest
Oct 31, 2022
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061594/0430 →
Merger
Oct 31, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 061594/0581 →
Change of Name
Oct 31, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 061808/0354 →